Phase I study of pembrolizumab in combination with ibrutinib for the treatment of unresectable or metastatic melanoma
Matthew Stephen Block, Robert R. McWilliams, Heather N. Montane, Allan B. Dietz et al.
Citations
1 citations
Journal
Frontiers in Immunology
Topics
Chronic Lymphocytic Leukemia Research
Field-Weighted Citation Impact (FWCI)
1.63
article
Phase I study of pembrolizumab in combination with ibrutinib for the treatment of unresectable or metastatic melanoma
Matthew Stephen Block, Robert R. McWilliams, Heather N. Montane, Allan B. Dietz, Courtney L. Erskine, Yuan Yao, Anastasios Dimou, Vera J. Suman, Svetomir N. Markovic, Yiyi Yan
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Frontiers in ImmunologyVol. 16
Institutions
Mayo Clinic (US), WinnMed (US), Mayo Clinic in Arizona (US), Mayo Clinic in Florida (US)